Universe Pharmaceuticals Inc.
UPC · NASDAQ
9/30/2024 | 9/30/2023 | 9/30/2022 | 9/30/2021 | |
|---|---|---|---|---|
| Revenue | $23,024 | $32,309 | $40,143 | $47,982 |
| % Growth | -28.7% | -19.5% | -16.3% | – |
| Cost of Goods Sold | $16,953 | $21,994 | $18,252 | $22,656 |
| Gross Profit | $6,072 | $10,315 | $21,891 | $25,326 |
| % Margin | 26.4% | 31.9% | 54.5% | 52.8% |
| R&D Expenses | $3,031 | $4,859 | $7,623 | $5,466 |
| G&A Expenses | $3,189 | $2,217 | $2,532 | $3,297 |
| SG&A Expenses | $10,444 | $9,001 | $21,295 | $6,270 |
| Sales & Mktg Exp. | $7,255 | $6,784 | $18,304 | $2,974 |
| Other Operating Expenses | $616 | -$18 | -$8 | $0 |
| Operating Expenses | $14,092 | $13,842 | $28,911 | $11,736 |
| Operating Income | -$8,020 | -$3,527 | -$7,019 | $13,590 |
| % Margin | -34.8% | -10.9% | -17.5% | 28.3% |
| Other Income/Exp. Net | -$101 | -$414 | -$545 | $58 |
| Pre-Tax Income | -$8,121 | -$3,941 | -$7,984 | $13,648 |
| Tax Expense | $607 | $2,254 | $752 | $2,359 |
| Net Income | -$8,727 | -$6,163 | -$8,737 | $11,320 |
| % Margin | -37.9% | -19.1% | -21.8% | 23.6% |
| EPS | -1,436.12 | -1,040.53 | -1,475.02 | 2,147.18 |
| % Growth | -38% | 29.5% | -168.7% | – |
| EPS Diluted | -1,436.12 | -1,040.53 | -1,475.02 | 2,147.18 |
| Weighted Avg Shares Out | 6 | 6 | 6 | 5 |
| Weighted Avg Shares Out Dil | 6 | 6 | 6 | 5 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $278 | $157 | $162 | $102 |
| Depreciation & Amortization | $486 | $509 | $534 | $447 |
| EBITDA | -$7,357 | -$3,184 | -$6,398 | $14,196 |
| % Margin | -32% | -9.9% | -15.9% | 29.6% |